This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Poretsky, L. Articles by Rosenwaks, Z. Search for Related Content PubMed PubMed Citation Articles by Poretsky, L. Articles by Rosenwaks, Z.

Phosphatidyl-Inositol-3 Kinase-Independent Insulin Action Pathway(s) in the Human Ovary¹

Division of Endocrinology (L.P., D.S.-Y., A.S.), Beth Israel Medical Center and Albert Einstein College of Medicine, New York, New York 10003; and Division of Endocrinology (L.P., S.D., M.M.) and Center for Reproductive Medicine and Infertility (L.P., H.-C.L., M.C.Y., Z.R.), Weill Medical College of Cornell University, New York, New York 10021

Address all correspondence and requests for reprints to: Leonid Poretsky, M.D., Division of Endocrinology, Beth Israel Medical Center, First Avenue at 16th Street, New York, New York 10003. E-mail: Lporetsk{at}bethisraelny.org

Abstract

Hyperandrogenism observed in women with a variety of insulin-resistant states is thought to be due to a stimulatory effect of insulin on ovarian steroid hormone production. However, it is not known what mechanisms could allow the ovary to remain sensitive to insulin while classical target organs for insulin action (liver, fat, and muscle) exhibit insulin resistance. One hypothesis proposed to explain this paradox suggests that a postbinding divergence of insulin receptor signaling occurs in the ovary and that signaling pathways for steroid hormone synthesis and other ovarian effects of insulin may be distinct from classical glucose signaling pathways. We now report that activation of phosphatidyl-inositol-3 (PI-3) kinase, which is crucial for glucose transport, is not necessary for the insulin-induced stimulation of progesterone production or for the insulin-induced inhibition of insulin-like growth factor binding protein 1 (IGFBP-1) production in cultured human ovarian cells.

Human granulosa cells obtained during in vitro fertilization procedures were cultured with 10, 10², 10³, or 10⁴ ng/mL insulin with or without preincubation with 100 nM wortmannin, a specific irreversible inhibitor of PI-3 kinase. IGFBP-1 concentration in the conditioned medium was measured using immunoradiometric assay or by Western blot analysis. Progesterone concentration was measured using RIA. Additional studies were carried out in cultures of human ovarian cells prepared from homogenized whole ovarian tissue of a woman with a family history of breast cancer and a mutation of BRCA-1 gene who underwent bilateral oophorectomy. These cells were cultured with 10³ ng/mL insulin with or without preincubation with 100 nM wortmannin.

Two-way ANOVA was used to compare mean values of IGFBP-1 and progesterone according to insulin dose and the use of wortmannin. In cultured granulosa cell medium, progesterone production was stimulated by insulin in a dose-related manner up to 175% of control (P < 0.0001). In tissue culture medium from ovarian cells obtained from a patient with BRCA-gene mutation, concentration of progesterone in the tissue culture medium increased from 2.5 ± 0.2 ng/mL for control to 5.4 ± 0.3 ng/mL for cells incubated with insulin (P < 0.001). IGFBP-1 production in tissue culture medium from human granulosa cells was inhibited by insulin to the nadir of 45% of control (P < 0.0001). Preincubation with wortmannin, despite complete inhibition of PI-3 kinase in both cell systems confirmed by Western blot analysis, failed to significantly alter these results.

We conclude that inhibition of PI-3 kinase by wortmannin fails to abolish stimulatory effect of insulin on progesterone production or inhibitory effect of insulin on IGFBP-1 production in cultured human ovarian cells. These findings suggest that activation of PI-3 kinase, an enzyme crucial for insulin-stimulated glucose transport, is not necessary for the above effects of insulin in the ovary. These data provide evidence for the presence of PI-3 kinase-independent insulin signaling pathway(s) in human ovarian cells.

This article has been cited by other articles:

				M. Jozwik, M. Jozwik, C. Teng, and F. C. Battaglia Concentrations of monosaccharides and their amino and alcohol derivatives in human preovulatory follicular fluid Mol. Hum. Reprod., November 1, 2007; 13(11): 791 - 796. [Abstract] [Full Text] [PDF]

				J M Silva, M Hamel, M Sahmi, and C A Price Control of oestradiol secretion and of cytochrome P450 aromatase messenger ribonucleic acid accumulation by FSH involves different intracellular pathways in oestrogenic bovine granulosa cells in vitro. Reproduction, December 1, 2006; 132(6): 909 - 917. [Abstract] [Full Text] [PDF]

				L. Poretsky Polycystic Ovary Syndrome--Increased or Preserved Ovarian Sensitivity to Insulin? J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2859 - 2860. [Full Text] [PDF]

				D. Seto-Young, M. Paliou, J. Schlosser, D. Avtanski, A. Park, P. Patel, K. Holcomb, P. Chang, and L. Poretsky Direct Thiazolidinedione Action in the Human Ovary: Insulin-Independent and Insulin-Sensitizing Effects on Steroidogenesis and Insulin-Like Growth Factor Binding Protein-1 Production J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6099 - 6105. [Abstract] [Full Text] [PDF]

				M. C. Richardson, I. T. Cameron, C. D. Simonis, M. C. Das, T. E. Hodge, J. Zhang, and C. D. Byrne Insulin and Human Chorionic Gonadotropin Cause a Shift in the Balance of Sterol Regulatory Element-Binding Protein (SREBP) Isoforms Toward the SREBP-1c Isoform in Cultures of Human Granulosa Cells J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3738 - 3746. [Abstract] [Full Text] [PDF]

				R. B. Lathi, A. P. Hess, S. Tulac, N. R. Nayak, M. Conti, and L. C. Giudice Dose-Dependent Insulin Regulation of Insulin-Like Growth Factor Binding Protein-1 in Human Endometrial Stromal Cells Is Mediated by Distinct Signaling Pathways J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1599 - 1606. [Abstract] [Full Text] [PDF]

				J. R. Wood, V. L. Nelson-Degrave, E. Jansen, J. M. McAllister, S. Mosselman, and J. F. Strauss III Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects Physiol Genomics, February 10, 2005; 20(3): 233 - 243. [Abstract] [Full Text] [PDF]

				J. L. Phy, C. A. Conover, D. H. Abbott, M. A. Zschunke, D. L. Walker, D. R. Session, I. S. Tummon, A. R. Thornhill, T. G. Lesnick, and D. A. Dumesic Insulin and Messenger Ribonucleic Acid Expression of Insulin Receptor Isoforms in Ovarian Follicles from Nonhirsute Ovulatory Women and Polycystic Ovary Syndrome Patients J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3561 - 3566. [Abstract] [Full Text] [PDF]

				I. Demeestere, C. Gervy, J. Centner, F. Devreker, Y. Englert, and A. Delbaere Effect of Insulin-Like Growth Factor-I During Preantral Follicular Culture on Steroidogenesis, In Vitro Oocyte Maturation, and Embryo Development in Mice Biol Reprod, June 1, 2004; 70(6): 1664 - 1669. [Abstract] [Full Text] [PDF]

				D. Seto-Young, J. Zajac, H.-C. Liu, Z. Rosenwaks, and L. Poretsky The Role of Mitogen-Activated Protein Kinase in Insulin and Insulin-Like Growth Factor I (IGF-I) Signaling Cascades for Progesterone and IGF-Binding Protein-1 Production in Human Granulosa Cells J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3385 - 3391. [Abstract] [Full Text] [PDF]